Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation.

Autor: Hannula-Jouppi K; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland; Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland. Electronic address: katariina.hannula-jouppi@hus.fi., Harjama L; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland., Einarsdottir E; Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden; Science for Life Laboratory, Department of Gene Technology, KTH-Royal Institute of Technology, Solna, Sweden., Elomaa O; Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland., Kettunen K; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Laboratory of Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Saarela J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway., Soronen M; PEDEGO Research Unit, University of Oulu and the Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland., Bouchard L; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland., Lappalainen K; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland., Heikkilä H; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland., Kivirikko S; Departments of Clinical Genetics and Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Seppänen MRJ; Rare Disease Center, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kere J; Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden; School of Basic and Medical Biosciences, King's College London, London, United Kingdom., Ranki A; Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Aug; Vol. 83 (2), pp. 643-645. Date of Electronic Publication: 2019 Nov 07.
DOI: 10.1016/j.jaad.2019.11.004
Databáze: MEDLINE